Prostate Cancer: Enough 'Me Too’ Drugs

What we need are affordability endpoints, effective surrogate endpoints, and better information for our clinical colleagues, contend Drs. Stéphane Oudard and Bertrand Tombal at ECC 2013.

Source: Medscape Urology Podcast - October 9, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts